Mindfulness app training for adolescents to reduce rumination
Official title: Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
Run by Mclean Hospital · NCT04697966 · Data updated 2026-11-12
This study is testing whether using a mindfulness app can help teenagers aged 13-18 feel less anxious and depressed by reducing their tendency to overthink.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 18 Years |
| Sex | All |
| Enrollment | 158 (estimated) |
| Sponsor | Mclean Hospital Academic / other |
| Locations | 1 site (Belmont, Massachusetts) |
| Status | Recruiting |
| Started | November 16, 2021 |
| Main results expected | May 31, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | June 17, 2026 |
| Trial ID | NCT04697966 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 13-18 who are experiencing rumination and have access to a personal smartphone.
✕Probably not a fit
Patients with a history of severe mental health disorders or those who do not meet the eligibility criteria for fMRI scanning may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of a mindfulness app, specifically Headspace, in reducing rumination and improving symptoms of depression and anxiety in adolescents aged 13-18. Participants will be randomly assigned to either the mindfulness app or an active control condition and will undergo pre- and post-intervention fMRI scans to explore the neural mechanisms involved. The research aims to identify the cognitive processes that contribute to the benefits of app-based mindfulness training and determine which adolescents may benefit most from this approach.
Why it matters
Potential benefit: If successful, this study could provide adolescents with an effective tool to manage rumination and reduce symptoms of depression and anxiety.
How similar studies have gone: While mindfulness apps have gained popularity, this study addresses critical gaps in understanding their effectiveness and mechanisms, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Both genders, all ethnicities (see Section: Inclusion of Women and Minorities) * Ages 13-18 years * Written informed assent/consent from adolescent and parent/guardian * English as a first language or English fluency * Right-handed * Personal iPhone or Android smartphone * CRSQ rumination subscale score * If on psychotropic medication, must be on stable dose for at least 2 months Exclusion Criteria: * History or current diagnosis of any of the following DSM-5 disorders: schizophrenia spectrum or other psychotic disorder, bipolar disorder, substance/alcohol use disorder within the past 12 months or lifetime severe substance/alcohol use disorder. * Systemic medical or neurological illness that could impact fMRI measures of cerebral blood flow * Failure to meet standard exclusion criteria for fMRI scanning (e.g. pregnancy, claustrophobia, cardiac or neural pacemakers, surgically implanted metal devices, cochlear implants, metal objects in the body) * History of seizure disorder, or head trauma with loss of consciousness \> 2 mins * Serious or unstable medical illness (e.g., cardiovascular, hepatic, renal, respiratory, endocrine, neurologic or hematologic disease) * Participants with active suicidal ideation will be immediately referred to appropriate clinical treatment. * Current or past treatment with mindfulness-based psychotherapy (e.g., MBCT, DBT or ACT) * Exposure to in-person or app-based mindfulness/meditation course (at least 300 mins of past practice)
Where it's running
-
McLean Hospital
Belmont, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Christian Webb, Phd
- Email: cwebb@mclean.harvard.edu
- Phone: 6178554429
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-enhanced imagery rescripting for anxiety tied to critical childhood memories
This trial will test whether AI-generated personalized scripts that guide imagery rescripting help adults aged 18–35 with elevated generalized anxiety reduce emotional and physiological reactions to critical childhood memories.
-
Readiness and Progress in Emotion Regulation Therapy
This trial will test if six modules of Emotion Regulation Therapy delivered by telehealth help adults in New York State with high worry, rumination, or self-criticism feel less anxious or depressed and function better.
-
Using AI to create personalized imagery rescripting scripts for adults with anxiety and fear of failure
This pilot will test whether AI-generated, personalized imagery rescripting audio can reduce emotional and physiological reactions in adults (18–35) with generalized anxiety, rumination, and fear of failure.
-
Modulating brain alpha rhythms to improve attentional control
This research will try an open-loop sham neurofeedback setup in adults with rumination or chronic pain (including fibromyalgia) to see if positive or negative feedback in virtual reality changes EEG alpha rhythms linked to attention.
-
Assessing Barrett's Esophagus in Patients with Anorexia Nervosa and Purging Behaviors
This study is trying to see if people with anorexia nervosa who purge have Barrett's esophagus, using non-invasive tests to check for this condition in patients aged 18-65.
-
Mindfulness and brain feedback for treating depression in teens
This study is testing a new way to help teens with depression by using mindfulness and brain feedback to see if it can reduce negative thinking and improve their mood.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.